Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TRVI
TRVI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TRVI News
Trevi Therapeutics (TRVI) Earnings Transcript
Mar 18 2026
NASDAQ.COM
Trevi Therapeutics Reports Narrowed Losses and Trial Updates
Mar 18 2026
NASDAQ.COM
Trevi Therapeutics Reports Key Insights from Q4 2025 Earnings Call
Mar 18 2026
seekingalpha
Trevi Therapeutics Advances Clinical Trials with Positive Data
Mar 18 2026
Yahoo Finance
Trevi Therapeutics Q4 Earnings Beat Expectations
Mar 17 2026
seekingalpha
Multiple Companies Set to Report Earnings
Mar 17 2026
NASDAQ.COM
Trevi Therapeutics Initiates Two Late-Stage Trials for Haduvio
Mar 09 2026
stocktwits
Trevi Therapeutics Initiates Two Phase 3 Trials for Chronic Cough Treatment
Mar 09 2026
Newsfilter
Trevi Therapeutics Reports Positive Phase 2b Results for Nalbuphine ER, Over 60% Cough Frequency Reduction at Week 6
Jan 22 2026
PRnewswire
Trevi Therapeutics Reports Significant Cough Frequency Reduction with Nalbuphine ER in Phase 2b Trial
Jan 22 2026
Newsfilter
Trevi Therapeutics Schedules Phase 2 Trials for Chronic Cough in 2026
Jan 08 2026
PRnewswire
Harvest Announces 2025 ETF Reinvested Distributions
Dec 31 2025
Businesswire
Harvest Announces Final Annual Reinvested Distributions for 2025 Tax Year
Dec 31 2025
Newsfilter
Harvest ETFs Updates 2025 Estimated Reinvested Distributions
Dec 22 2025
Businesswire
Inaugural Week of TRVI Options Trading for February 2026
Dec 19 2025
NASDAQ.COM
Trevi Therapeutics Appoints New CFO to Drive Haduvio Development
Dec 04 2025
PRnewswire
Show More News
